{"name":"Oculus Innovative Sciences, Inc.","slug":"oculus-innovative-sciences-inc","ticker":"","exchange":"","domain":"","description":"Oculus Innovative Sciences, Inc. is a biotechnology company focused on developing and commercializing innovative antimicrobial products for the healthcare market. The company's pipeline includes three drugs in Phase 2 clinical trials, all of which are designed to address unmet medical needs in wound care and infection prevention.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":14288000,"revenueGrowth":12.2,"grossMargin":38.2,"rdSpend":1814000,"netIncome":-3457000,"cash":5374000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-03-12","type":"pipeline","source":"GlobeNewswire","summary":"Pharmaceutical and Biotechnology Royalty Rates Agreements - GlobeNewswire","headline":"Pharmaceutical and Biotechnology Royalty Rates Agreements","sentiment":"neutral"},{"date":"2026-02-10","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: FORM 10-Q FOR DEC 2025","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2026-01-28","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"date":"2026-01-12","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"date":"2026-01-02","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"date":"2025-11-04","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: FORM 10-Q FOR SEP 2025","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2025-10-23","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"date":"2025-10-09","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"date":"2025-09-29","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"date":"2025-09-26","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"date":"2025-08-29","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"date":"2025-08-07","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: FORM 10-Q FOR JUNE 2025","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywJBVV95cUxONE5rdUczeUllVUM2cm0yYXRLSVFQZnJMOENGamI0dzBKclp4Q01fbWMzQXhYQlJfd3NFMVhSQVhUcmsxbXdQQXI5aXNLMGJMUnhja1lIUXV2RzlwVXJNVlkzLXRVbDI0MTFEZlB5Snh2N0dfMXZHUXZGTjhqS2h4NGptWC1SbWJtNFgzRXVzY044TUZHUE00bmdhOVNraUxCc2w4NlhVX0YxRmY1WDFvMXBLYjN2N2JrQXNfVUZBWTM1TlFrUGszVm9pS3k0MWpBR0xkcjF6SmY5VnVWVXVLZjdmQUNKTUdJSV9vc2lrT1FoZ2VhbVlUMjQtQkxTUEJTbFFrTXNHVWU4a3lkOUw1bzEtUmNWRkROS2RpeTNESzFJdGxkUUlDeGkxX0hwNEtycWxiaGswSldfYUVZNkhlMTFKbHNUV1h4UWxr?oc=5","date":"2016-12-05","type":"pipeline","source":"GlobeNewswire","summary":"Oculus Innovative Sciences Announces Corporate Name Change - GlobeNewswire","headline":"Oculus Innovative Sciences Announces Corporate Name Change","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2015-05-29","type":"deal","source":"Express Computer","summary":"Oculus partners with Genetix Biotech to launch wound care products - Express Computer","headline":"Oculus partners with Genetix Biotech to launch wound care products","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar","revenue":14288000,"revenuePeriod":"2025-03-31","revenueHistory":[{"value":14288000,"period":"2025-03-31"},{"value":12735000,"period":"2024-03-31"},{"value":13272000,"period":"2023-03-31"},{"value":12628000,"period":"2022-03-31"},{"value":18629000,"period":"2021-03-31"},{"value":18970000,"period":"2019-03-31"}],"grossProfit":5465000,"grossProfitHistory":[],"rdSpend":1814000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-3457000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":5374000,"cashHistory":[],"totalAssets":13693000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":null}